Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Aurora Cannabis Inc    ACB   CA05156X1087

AURORA CANNABIS INC (ACB)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Canada's Aurora Cannabis boosts stake in Australia-based Cann Group

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/04/2017 | 05:19pm CEST

(Reuters) - Canada's Aurora Cannabis Inc (>> Aurora Cannabis Inc) said on Monday it increased its stake in Australia-based Cann Group Ltd (>> Cann Group Ltd) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

(Reuters) - Canada's Aurora Cannabis Inc (>> Aurora Cannabis Inc) said on Monday it increased its stake in Australia-based Cann Group Ltd (>> Cann Group Ltd) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

Aurora, already Cann Group's largest shareholder, said it bought the shares at A$2.50 ($1.90) apiece.

Shares of Cann Group ended 4.7 percent higher at A$3.14 on the Australian Stock Exchange on Monday.

Cann Group was the first Australian company to receive a license to research and cultivate cannabis for medical purposes.

Aurora will also invest C$12 million ($9.4 million) in Canadian biotechnology company Radient Technologies Inc <RTI.V>. The investment will increase Aurora's stake in Radient to 19.18 percent from 8.8 percent.

The investments come as Aurora - one of Canada's biggest cannabis makers - looks to expand ahead of expectations that Canada will legalize the production, sale and consumption of recreational marijuana.

Aurora is also trying to buy medical marijuana company CanniMed Therapeutics Inc (>> CanniMed Therapeutics Inc), which last week adopted a "poison pill" plan to prevent a takeover.

Radient's stock rose nearly 10 percent on Monday on the TSX Venture Exchange.

(Reporting by Yashaswini Swamynathan and Taenaz Shakir in Bengaluru; editing by Sai Sachin Ravikumar)

Stocks mentioned in the article
ChangeLast1st jan.
CANN GROUP LTD -3.05% 2.86 End-of-day quote.7.66%
CANNIMED THERAPEUTICS INC 0.00%-End-of-day quote.19.73%
S&P/TSX COMPOSITE INDEX -0.50% 16356.05 Delayed Quote.1.49%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AURORA CANNABIS INC
01:01pAURORA CANNABIS : Ships Products to Maltese Medical Cannabis Market
AQ
06/22TODAY'S RESEARCH REPORTS ON TRENDING : MedReleaf and Aurora Cannabis
AC
06/21AURORA CANNABIS : Welcomes Royal Assent of Canada's Cannabis Act
PR
06/21AURORA CANNABIS : Welcomes Royal Assent of Canada's Cannabis Act
AQ
06/21Colombia Quickly Becoming a Global Leader in Medical Marijuana
AQ
06/21Canada sets October start for legal recreational marijuana sales
RE
06/20AURORA CANNABIS : Announces Mailing of Management Information Circular with Resp..
AQ
06/20AURORA CANNABIS : to spin off U.S. holdings to publicly traded Australis Capital
AQ
06/20AURORA CANNABIS : to Issue Return of Capital to Shareholders via Spin-Out of U.S..
AQ
06/19AURORA CANNABIS : Most actively traded companies on the TSX
AQ
More news
News from SeekingAlpha
06/22Marijuana Is Legalized In Canada - Bill C-45 Passes With 27 Amendments Accept.. 
06/22Molson Coors in talks with marijuana companies - Bloomberg 
06/21CANADIAN LEGALIZATION : What's Next For Cannabis Stocks? 
06/20Aurora Cannabis to spin off subsidiary aimed at U.S. investments; shares up 5.. 
06/20Canadian Senate backs legalization of recreational pot 
Financials ( CAD)
Sales 2018 62,0 M
EBIT 2018 -2,34 M
Net income 2018 -67,3 M
Finance 2018 20,0 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019 199,80
EV / Sales 2018 90,1x
EV / Sales 2019 12,2x
Capitalization 5 610 M
Chart AURORA CANNABIS INC
Duration : Period :
Aurora Cannabis Inc Technical Analysis Chart | ACB | CA05156X1087 | 4-Traders
Technical analysis trends AURORA CANNABIS INC
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 9,63  CAD
Spread / Average Target -3,7%
EPS Revisions
Managers
NameTitle
Terry Booth Chief Executive Officer & Non-Independent Director
Steve Dobler President & Director
Michael Singer Chairman
Allan Cleiren Chief Operating Officer
Glen W. Ibbott Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
AURORA CANNABIS INC4.06%4 225
BEIJING TONGRENTANG CO., LTD.15.76%7 871
CANOPY GROWTH CORP46.03%6 566
DONG-E-E-JIAO CO LTD--.--%5 519
HUTCHISON CHINA MEDITECH LIMITED-18.39%4 028
MEDRELEAF CORP44.44%2 196